CompuGroup stock slips as investors await fresher numbers
Published on 08/19/2026 at 15:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CompuGroup Medical SE & Co. KGaA (ISIN DE000A288904) is trading in a market where the broad backdrop stayed firm on August 19, 2026, while the company's own latest published operating figures remain the key reference for investors. The most recent report period visible in the available source set is fiscal 2025, which makes that the benchmark for revenue, earnings and margin context.
Latest reported base
Historical context matters here: in fiscal 2025, CompuGroup reported revenue of EUR 1.14 billion, adjusted EBITDA of EUR 232.8 million and a margin of 20.4%. Those figures were higher than the prior year on revenue but came with a margin profile that still sits at the center of the re-rating debate.
The comparison is concrete: revenue increased by EUR 44.4 million from the prior year's EUR 1.096 billion, while adjusted EBITDA rose by EUR 12.6 million from EUR 220.2 million. That gap is large enough to keep earnings quality in view even without a fresh quarter in the current result set.
What investors are watching
For CompuGroup, the key question is whether the next report will confirm that the revenue base can keep expanding faster than cost growth. The company name itself carries that tension, because a software group with recurring healthcare billing and practice-management revenue needs steady conversion into cash and profit.
The broader market tone remains relevant as well. Bloomberg Markets showed 26,289.71 points for the U.S. stock benchmark on August 19, 2026, after a 3.48% move over the recent stretch, and that kind of backdrop helps frame risk appetite for European software names.
Investor focus
CompuGroup's product set centers on software for medical practices, pharmacies and other healthcare providers, so revenue visibility depends heavily on customer retention, implementation pace and recurring service contracts. That business mix is why the margin line still matters more than headline growth alone.
Stock level and timing
CompuGroup shares are best read against the next earnings date of August 26, 2026, which gives the market a concrete timing marker for the next update. Until then, the stock story is driven more by the balance between fiscal 2025 growth and the outlook implied by the next filing.
Price data for the current session was not supported in the available source set, so the cleaner market reference is the most recent reported fundamentals and the dated earnings calendar. That keeps the article anchored to verified numbers rather than a stale quote.
Company facts
Company: CompuGroup Medical SE & Co. KGaA
ISIN: DE000A288904
Ticker: C9F
Exchange: Xetra
Sector / Industry: Health Care Technology / Health Care Software
Next earnings date: August 26, 2026
About CompuGroup Medical
CompuGroup Medical develops software for doctors, dentists, pharmacies, hospitals and other healthcare organizations. Its core business is built around recurring software and service relationships, which is why the latest reported revenue and margin figures matter so much for valuation.
Market view
CompuGroup stock remains a date-driven story into the next update, with fiscal 2025 revenue at EUR 1.14 billion, adjusted EBITDA at EUR 232.8 million and a margin of 20.4%. Those are the numbers investors will compare against when the next report arrives on August 26, 2026.
Media Description
CompuGroup stock with healthcare software focus
Media Alt
CompuGroup stock in healthcare software
